Molecular Intravascular Imaging Approaches for Atherosclerosis

Current Cardiovascular Imaging Reports

Volumn 7, Issue 10, 2014, Pages

  Press, Marcella Calfon ^a   Jaffer, Farouc A ^b  

^a UCLA MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Atherosclerosis; Fibrin; Inflammation; Intravascular imaging; Molecular imaging; Near infraredl fluorescence imaging; Optical coherence tomography; Optical frequency domain imaging; Stent; Vulnerable plaque

Indexed keywords

FLUORODEOXYGLUCOSE F 18; INDOCYANINE GREEN;

ATHEROSCLEROSIS; CARDIOVASCULAR SYSTEM EXAMINATION; CORONARY ARTERY DISEASE; CORONARY STENT; FEASIBILITY STUDY; FLUORESCENCE IMAGING; HUMAN; INFLAMMATION; MOLECULAR IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL FREQUENCY DOMAIN COHERENCE TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; REVIEW; TWO DIMENSIONAL NEAR INFRARED FLUORESCENCE;

EID: 84919933775     PISSN: 19419066     EISSN: 19419074     Source Type: Journal    
DOI: 10.1007/s12410-014-9293-x     Document Type: Review

References (20)

1. Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364(3):226–35.
2. Jaffer FA, Libby P, Weissleder R. Molecular imaging of cardiovascular disease. Circulation. 2007;116(9):1052–61.
3. Sanz J, Fayad ZA. Imaging of atherosclerotic cardiovascular disease. Nature. 2008;451(7181):953–7.
4. Quillard T, Libby P. Molecular imaging of atherosclerosis for improving diagnostic and therapeutic development. Circ Res. 2012;111(2):231–44.
5. Osborn EA, Jaffer FA. The advancing clinical impact of molecular imaging in CVD. JACC Cardiovasc Imaging. 2013;6(12):1327–41.
6. Verjans JW, van de Borne SW, Hofstra L, Narula J. Molecular imaging of myocardial remodeling after infarction. Methods Mol Biol. 2011;680:227–35.
7. Calfon MA, Vinegoni C, Ntziachristos V, Jaffer FA. Intravascular near-infrared fluorescence molecular imaging of atherosclerosis: toward coronary arterial visualization of biologically high-risk plaques. J Biomed Opt. 2010;15(1):011107.
8. Tang TY, Howarth SP, Miller SR, Graves MJ, Patterson AJ JMUK-I, et al. The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. J Am Coll Cardiol. 2009;53(22):2039–50.
9. Tawakol A, Migrino RQ, Bashian GG, Bedri S, Vermylen D, Cury RC, et al. In vivo 18 F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol. 2006;48(9):1818–24.
10. Rogers IS, Nasir K, Figueroa AL, Cury RC, Hoffmann U, Vermylen DA, et al. Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina. JACC Cardiovasc Imaging. 2010;3(4):388–97.
11. Joshi NV, Vesey AT, Williams MC, Shah AS, Calvert PA, Craighead FH, et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet. 2014;383(9918):705–13. This is the first non invasive imaging method able to identify and localize ruptured and potenitally high-risk coronary plaques using 18F-NaF PET-CT of plaque osteogenesis.
12. Jaffer FA, Kim DE, Quinti L, Tung CH, Aikawa E, Pande AN, et al. Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor. Circulation. 2007;115(17):2292–8.
13. Jaffer FA. Intravital fluorescence microscopic molecular imaging of atherosclerosis. Methods Mol Biol. 2011;680:131–40.
14. Jaffer FA, Calfon MA, Rosenthal A, Mallas G, Razansky RN, Mauskapf A, et al. Two-dimensional intravascular near-infrared fluorescence molecular imaging of inflammation in atherosclerosis and stent-induced vascular injury. J Am Coll Cardiol. 2011;57(25):2516–26.
15. Jaffer FA, Vinegoni C, John MC, Aikawa E, Gold HK, Finn AV, et al. Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis. Circulation. 2008;118(18):1802–9.
16. Yoo H, Kim JW, Shishkov M, Namati E, Morse T, Shubochkin R, et al. Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo. Nat Med. 2011;17(12):1680–4.
17. Hara T, Bhayana B, Thompson B, Kessinger CW, Khatri A, McCarthy JR, et al. Molecular imaging of fibrin deposition in deep vein thrombosis using fibrin-targeted near-infrared fluorescence. JACC Cardiovasc Imaging. 2012;5(6):607–15. First intravenous injectable NIRF fibrin-targted agent for intravascular NIRF imaging.
18. Hara T, McCarthy JR, Hamidi E, Erdem S, Mauskapf A, Bouma B, Tearney G, Jaffer F. Intravascular Optical Molecular Imaging of fibrin deposition to assess vascular healing after coronary stent implantation. Circulation. [Abstract]. 2012;126.
19. Vinegoni C, Botnaru I, Aikawa E, Calfon MA, Iwamoto Y, Folco EJ, et al. Indocyanine green enables near-infrared fluorescence imaging of lipid-rich, inflamed atherosclerotic plaques. Sci Transl Med. 2011;3(84):84ra45.
20. van Dam GM, Themelis G, Crane LM, Harlaar NJ, Pleijhuis RG, Kelder W, et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: first in-human results. Nat Med. 2011;17:1315–9.